Biophoton Therapy for Type 2 Diabetes Patients

This clinical trial explores the effectiveness of Biophoton Therapy for adults with Type 2 Diabetes. The study aims to determine if using a device called the Tesla BioHealing Biophotonizer-A can help improve blood glucose levels, overall metabolism, and quality of life in people with this condition. The study is important as it could offer new, non-invasive treatment options for managing diabetes, potentially improving blood sugar control and reducing diabetes-related symptoms and complications. Participants will use either active or placebo Biophoton devices placed on each side of their bed while they sleep for eight hours every night over two months. Initially, for four weeks, the trial is double-blinded, meaning neither the participants nor the researchers know who is receiving the real treatment. After this period, all participants will receive the active treatment. Throughout the study, various health indicators such as fasting glucose, blood pressure, and quality of life will be measured at regular intervals to assess the therapy's impact. The study will also monitor any side effects to ensure participant safety.